Actively Recruiting

Age: 18Years - 80Years
All Genders
NCT05586243

MAGNETIC RESONANCE SPECTROSCOPY BIOMARKERS IN TYPE 3 GAUCHER DISEASE (GD3)

Led by University of Minnesota · Updated on 2026-01-08

5

Participants Needed

1

Research Sites

186 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Recent studies have has shown that magnetic resonance spectroscopy (MRS) can provide validated neuronal markers in patients with Type 1 GD (GD1) who are on stable therapy. However, alterations in neurometabolites in adult patients with GD3, who have established neurological involvement, are not well understood. The goal of this study is to characterize neurometabolite profiles in adult patients with GD3 using MRS to identify novel biomarkers that can demonstrate treatment response. Additionally, a secondary aim is to evaluate relationships between neurometabolites and disease parameters, such as genotype, enzyme levels and Gaucher disease (GD) biomarkers.

CONDITIONS

Official Title

MAGNETIC RESONANCE SPECTROSCOPY BIOMARKERS IN TYPE 3 GAUCHER DISEASE (GD3)

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Must be 18 years or older
  • Must understand and cooperate with study requirements
  • Must provide written informed consent
  • Must have Type 3 Gaucher Disease and be medically stable for participation as judged by the investigator
Not Eligible

You will not qualify if you...

  • Medically unstable conditions
  • Other diseases or circumstances that could affect safety, study compliance, or data integrity
  • Women who are pregnant, lactating, or of child-bearing age not using contraception
  • Participation in another interventional study
  • Unable or unwilling to have blood drawn
  • Unable to undergo MRI scanning due to inability to stay still, claustrophobia, metal implants, pacemakers, or weight over 300 lbs
  • Unable to follow study protocol for any reason

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Minnesota

Minneapolis, Minnesota, United States, 55455

Actively Recruiting

Loading map...

Research Team

R

Reena Kartha, PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here